AAAAAA

   
Results: 1-24 |
Results: 24

Authors: BEREGI JP LAHOCHE A WILLOTEAUX S MCFADDEN E BORDET R GAUTIER C ETCHRIVI T
Citation: Jp. Beregi et al., RENAL-ARTERY VASOMOTION - IN-VIVO ASSESSMENT IN THE PIG WITH INTRAVASCULAR DOPPLER, Fundamental and clinical pharmacology, 12(6), 1998, pp. 613-618

Authors: ADAMANTIDIS MM DUMOTIER BM CARON JF BORDET R
Citation: Mm. Adamantidis et al., SPARFLOXACIN BUT NOT LEVOFLOXACIN OR OFLOXACIN PROLONGS CARDIAC REPOLARIZATION IN RABBIT PURKINJE-FIBERS, Fundamental and clinical pharmacology, 12(1), 1998, pp. 70-76

Authors: SCHWARTZ JC DIAZ J BORDET R GRIFFON N PERACHON S PILON C RIDRAY S SOKOLOFF P
Citation: Jc. Schwartz et al., FUNCTIONAL IMPLICATIONS OF MULTIPLE DOPAMINE-RECEPTOR SUBTYPES - THE D-1 D-3 RECEPTOR COEXISTENCE/, Brain research reviews, 26(2-3), 1998, pp. 236-242

Authors: SCHWARTZ JC DIAZ J BORDET R GRIFFON N PERACHON S PILON C RIDRAY S SOKOLOFF P
Citation: Jc. Schwartz et al., THE D-3 RECEPTOR AND ITS LIGANDS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 41-41

Authors: SIX I VANBELLE E VALLET B CORSEAX D BORDET R LETOURNEAU T DUPUIS B BAUTERS C BARTRAND ME
Citation: I. Six et al., FGF - A PROTECTIVE FACTOR FOR ENDOTHELIAL-CELLS IN THE EARLY STAGES OF ATHEROSCLEROSIS, Circulation, 98(17), 1998, pp. 185-185

Authors: BORDET R THOMAS P DUPUIS B
Citation: R. Bordet et al., EFFECT OF PINDOLOL ON ONSET OF ACTION OF PAROXETINE IN THE TREATMENT OF MAJOR DEPRESSION - INTERMEDIATE ANALYSIS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The American journal of psychiatry, 155(10), 1998, pp. 1346-1351

Authors: BORDET R VERWAERDE P TRAN MA MARQUES MA MONTASTRUC JL SENARD JM
Citation: R. Bordet et al., EFFECTS OF OCTREOTIDE ON EXPERIMENTAL NEUROGENIC ORTHOSTATIC HYPOTENSION IN ANESTHETIZED DOGS, Fundamental and clinical pharmacology, 11(3), 1997, pp. 237-244

Authors: BORDET R THOMAS P
Citation: R. Bordet et P. Thomas, SELECTIVE SEROTONIN REUPTAKE INHIBITORS PLUS PINDOLOL, Lancet, 350(9073), 1997, pp. 289-289

Authors: BEREGI J GAUTIER C MACFADDEN E LIBERSA C BORDET R MOUNIERVEHIER C
Citation: J. Beregi et al., VASOMOTOR RESPONSE OF NON-STENOSED RENAL-ARTERIES IN PATIENTS WITH SYSTEMIC HYPERTENSION - AN INTRAVASCULAR DOPPLER STUDY, Radiology, 205, 1997, pp. 1518-1518

Authors: BORDET R BELABBAS A LHERMITTE M TRICOT O ROUSSEL P LIBERSA C
Citation: R. Bordet et al., IS THERE ANY DIFFERENCE BETWEEN DAYTIME AND NIGHTTIME DEBRISOQUINE METABOLISM, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 419-420

Authors: BORDET R RIDRAY S CARBON S DIAZ J SOKOLOFF P SCHWARTZ JC
Citation: R. Bordet et al., INDUCTION OF DOPAMINE D-3 RECEPTOR EXPRESSION AS A MECHANISM OF BEHAVIORAL SENSITIZATION TO LEVODOPA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(7), 1997, pp. 3363-3367

Authors: REMY J DESCHILDRE F ARTAUD D REMYJARDIN M COPIN MC BORDET R GOSSELIN B
Citation: J. Remy et al., BRONCHIAL ARTERIES IN THE PIG BEFORE AND AFTER PERMANENT PULMONARY-ARTERY OCCLUSION, Investigative radiology, 32(4), 1997, pp. 218-224

Authors: SIX I VANBELLE E BORDET R CORSEAUX D MEURICE T DUPUIS B BAUTERS C BERTRAND ME
Citation: I. Six et al., NITRIC-OXIDE IS NOT INVOLVED IN ENDOTHELIAL REGROWTH IN-VIVO - RESULTS IN A RABBIT BALLOON INJURY MODEL, Circulation, 96(8), 1997, pp. 3087-3087

Authors: BORDET R BENHADJALI J DESTEE A HURTEVENT JF BOURRIEZ JL GUIEU JD
Citation: R. Bordet et al., SYMPATHETIC SKIN-RESPONSE AND R-R INTERVAL VARIABILITY IN MULTIPLE SYSTEM ATROPHY AND IDIOPATHIC PARKINSONS-DISEASE, Movement disorders, 11(3), 1996, pp. 268-272

Authors: BORDET R BROLY F DESTEE A LIBERSA C LAFITTE JJ
Citation: R. Bordet et al., LACK OF RELATION BETWEEN GENETIC-POLYMORPHISM OF CYTOCHROME P-450IID6AND SPORADIC IDIOPATHIC PARKINSONS-DISEASE, Clinical neuropharmacology, 19(3), 1996, pp. 213-221

Authors: VERWAERDE P BORDET R PORTOLAN G TRAN MA MARQUES MA MONTASTRUC JL SENARD JM
Citation: P. Verwaerde et al., LACK OF EFFECT OF OCTREOTIDE ON EXPERIMEN TAL ORTHOSTATIC HYPOTENSIONIN SINOAORTIC DENERVATED DOGS, Archives des maladies du coeur et des vaisseaux, 89(8), 1996, pp. 1097-1101

Authors: VERMERSCH P BORDET R LEDOZE F RUCHOUX MM CHAPON F THOMAS P DESTEE A LECHEVALLIER B DELACOURTE A
Citation: P. Vermersch et al., DEMONSTRATION OF A SPECIFIC PROFILE OF PA THOLOGICAL TAU-PROTEINS IN FRONTOTEMPORAL DEMENTIA CASES, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 318(4), 1995, pp. 439-445

Authors: BORDET R BENHADJALI J DESTEE A BELABBAS A LIBERSA C
Citation: R. Bordet et al., OCTREOTIDE EFFECTS ON ORTHOSTATIC HYPOTENSION IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY - A CONTROLLED-STUDY OF ACUTE ADMINISTRATION, Clinical neuropharmacology, 18(1), 1995, pp. 83-89

Authors: LIBERSA C BORDET R CARON J GUEDONMOREAU L
Citation: C. Libersa et al., VASCULAR IMPACT OF DIHYDROPYRIDINES CALCI UM-ANTAGONISTS, Therapie, 50(2), 1995, pp. 101-108

Authors: BORDET R BROLY F DESTEE A LIBERSA C
Citation: R. Bordet et al., GENETIC-POLYMORPHISM OF CYTOCHROME-P450 2D6 IN IDIOPATHIC PARKINSON DISEASE AND DIFFUSE LEWY BODY DISEASE, Clinical neuropharmacology, 17(5), 1994, pp. 484-488

Authors: BORDET R BENHADJALI J LIBERSA C DESTEE A
Citation: R. Bordet et al., OCTREOTIDE IN THE MANAGEMENT OF ORTHOSTATIC HYPOTENSION IN MULTIPLE SYSTEM ATROPHY - PILOT TRIAL OF CHRONIC ADMINISTRATION, Clinical neuropharmacology, 17(4), 1994, pp. 380-383

Authors: LIBERSA C CARON J GUEDONMOREAU L TRICOT O BORDET R
Citation: C. Libersa et al., METHODS OF ANTIARRHYTHMIC DRUGS EVALUATIO N IN HUMANS, Therapie, 49(3), 1994, pp. 201-209

Authors: BORDET R CARON J DESTEE A DUPUIS B
Citation: R. Bordet et al., PROGRESSIVE MUSCULAR-DYSTROPHY AND MEDICI NAL RISK, Therapie, 49(2), 1994, pp. 129-132

Authors: BORDET R BENHADJALI J LIBERSA C DESTEE A
Citation: R. Bordet et al., OCTREOTIDE EFFECTS ON ORTHOSTATIC HYPOTENSION IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY - A CONTROLLED-STUDY OF ACUTE ADMINISTRATION, Neurology, 44(4), 1994, pp. 10000219-10000219
Risultati: 1-24 |